TCM
Tekla Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-300,000
| Closed | -$3.15M | – | 182 |
|
|
2022
Q4 | $3.15M | Hold |
300,000
| – | – | 0.12% | 96 |
|
|
2022
Q3 | $2.39M | Buy |
+300,000
| New | +$2.39M | 0.1% | 109 |
|
|
2022
Q2 | – | Sell |
-250,000
| Closed | -$2.78M | – | 178 |
|
|
2022
Q1 | $2.78M | Hold |
250,000
| – | – | 0.1% | 114 |
|
|
2021
Q4 | $2.47M | Hold |
250,000
| – | – | 0.08% | 124 |
|
|
2021
Q3 | $2.47M | Hold |
250,000
| – | – | 0.08% | 132 |
|
|
2021
Q2 | $2.58M | Hold |
250,000
| – | – | 0.08% | 147 |
|
|
2021
Q1 | $2.56M | Hold |
250,000
| – | – | 0.09% | 152 |
|
|
2020
Q4 | $2.71M | Buy |
+250,000
| New | +$2.71M | 0.1% | 146 |
|